MARKER THERAPEUTICS INC

The current price of GX1 is 2.18 EUR — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MARKER THERAPEUTICS INC stocks are traded under the ticker GX1.

MARKER THERAPEUTICS INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

GX1 stock is 0% volatile and has beta coefficient of 1.33. Check out the list of the most volatile stocks — is MARKER THERAPEUTICS INC there?

GX1 earnings for the last quarter are −0.32 EUR per share, whereas the estimation was −0.85 EUR resulting in a 62.22% surprise. The estimated earnings for the next quarter are −0.82 EUR per share. See more details about MARKER THERAPEUTICS INC earnings.

MARKER THERAPEUTICS INC revenue for the last quarter amounts to ‪754.30 K‬ EUR despite the estimated figure of ‪2.39 M‬ EUR. In the next quarter revenue is expected to reach ‪408.15 K‬ EUR.

GX1 net income for the last quarter is ‪−2.48 M‬ EUR, while the quarter before that showed ‪−2.82 M‬ EUR of net income which accounts for 11.99% change. Track more MARKER THERAPEUTICS INC financial stats to get the full picture.

Today MARKER THERAPEUTICS INC has the market capitalization of ‪34.17 M‬, it has increased by 0.38% over the last week.

No, GX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKER THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.

GX1 reached its all-time high on Jan 30, 2023 with the price of 3.22 EUR, and its all-time low was 2.17 EUR and was reached on Feb 8, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 30, 2024, the company has 8.00 employees. See our rating of the largest employees — is MARKER THERAPEUTICS INC on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKER THERAPEUTICS INC EBITDA is ‪−12.19 M‬ EUR, and current EBITDA margin is −440.37%. See more stats in MARKER THERAPEUTICS INC financial statements.